Mylan Reports Record Third Quarter Revenue and Increases Fiscal 2003 Earnings Guidance.

Business Editors

PITTSBURGH, Pa.--(BUSINESS WIRE)--Jan. 30, 2003

Mylan Laboratories Inc. (NYSE: MYL):

Mylan Announces Fiscal 2004 Earnings Guidance

Financial Highlights

 
-- our ability to successfully develop, license or otherwise acquire and introduce new products on a timely basis in relation to competing product introductions; 
 
-- our ability to obtain required FDA approvals for new products on a timely basis; 
 
-- uncertainties regarding continued market acceptance of and demand for our products; 
 
-- our periodic dependence on a relatively small group of products as a significant source of our net revenue or net income; 
  ...